Intuitive Surgical, Inc. Revenue
Intuitive Surgical, Inc. (ISRG) reported Revenue of $2.89 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-21
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $2.89B, a 18.54% increase year-over-year.
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $2.77B, a 22.96% increase year-over-year.
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $2.87B, a 18.76% increase year-over-year.
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $2.51B, a 22.91% increase year-over-year.
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $10.06B, a 20.51% increase from fiscal 2024.
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $8.35B, a 17.24% increase from fiscal 2023.
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $7.12B, a 14.49% increase from fiscal 2022.
- Intuitive Surgical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $6.22B, a 8.97% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.89B 10-Q · filed 2026-07-21 | $5.66B 10-Q · filed 2026-07-21 | $8.53B derived: sum of 3 quarters · filed 2026-07-21 | $11.03B derived: sum of 4 quarters · filed 2026-07-21 |
| 2026-03-31 | $2.77B 10-Q · filed 2026-04-22 | $5.64B derived: sum of 2 quarters · filed 2026-04-22 | $8.14B derived: sum of 3 quarters · filed 2026-04-22 | $10.58B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-12-31 | $2.87B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $5.37B derived: sum of 2 quarters · filed 2026-02-03 | $7.81B derived: sum of 3 quarters · filed 2026-07-21 | $10.06B 10-K · filed 2026-02-03 |
| 2025-09-30 | $2.51B 10-Q · filed 2025-10-22 | $4.95B derived: sum of 2 quarters · filed 2026-07-21 | $7.20B 10-Q · filed 2025-10-22 | $9.61B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-06-30 | $2.44B 10-Q · filed 2026-07-21 | $4.69B 10-Q · filed 2026-07-21 | $7.11B derived: sum of 3 quarters · filed 2026-07-21 | $9.14B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-03-31 | $2.25B 10-Q · filed 2026-04-22 | $4.67B derived: sum of 2 quarters · filed 2026-04-22 | $6.71B derived: sum of 3 quarters · filed 2026-04-22 | $8.71B derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $2.41B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $4.45B derived: sum of 2 quarters · filed 2026-02-03 | $6.46B derived: sum of 3 quarters · filed 2026-02-03 | $8.35B 10-K · filed 2026-02-03 |
| 2024-09-30 | $2.04B 10-Q · filed 2025-10-22 | $4.05B derived: sum of 2 quarters · filed 2025-10-22 | $5.94B 10-Q · filed 2025-10-22 | $7.87B derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $2.01B 10-Q · filed 2025-07-23 | $3.90B 10-Q · filed 2025-07-23 | $5.83B derived: sum of 3 quarters · filed 2026-02-03 | $7.57B derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $1.89B 10-Q · filed 2025-04-23 | $3.82B derived: sum of 2 quarters · filed 2026-02-03 | $5.56B derived: sum of 3 quarters · filed 2026-02-03 | $7.32B derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $1.93B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $3.67B derived: sum of 2 quarters · filed 2026-02-03 | $5.43B derived: sum of 3 quarters · filed 2026-02-03 | $7.12B 10-K · filed 2026-02-03 |
| 2023-09-30 | $1.74B 10-Q · filed 2024-10-18 | $3.50B derived: sum of 2 quarters · filed 2024-10-18 | $5.20B 10-Q · filed 2024-10-18 | $6.85B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-06-30 | $1.76B 10-Q · filed 2024-07-19 | $3.45B 10-Q · filed 2024-07-19 | $5.11B derived: sum of 3 quarters · filed 2025-01-31 | $6.66B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-03-31 | $1.70B 10-Q · filed 2024-04-19 | $3.35B derived: sum of 2 quarters · filed 2025-01-31 | $4.91B derived: sum of 3 quarters · filed 2025-01-31 | $6.43B derived: sum of 4 quarters · filed 2025-01-31 |
| 2022-12-31 | $1.66B derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $3.21B derived: sum of 2 quarters · filed 2025-01-31 | $4.73B derived: sum of 3 quarters · filed 2025-01-31 | $6.22B 10-K · filed 2025-01-31 |
| 2022-09-30 | $1.56B 10-Q · filed 2023-10-20 | $3.08B derived: sum of 2 quarters · filed 2023-10-20 | $4.57B 10-Q · filed 2023-10-20 | $6.12B derived: sum of 4 quarters · filed 2023-10-20 |
| 2022-06-30 | $1.52B 10-Q · filed 2023-07-24 | $3.01B 10-Q · filed 2023-07-24 | $4.56B derived: sum of 3 quarters · filed 2023-07-24 | $5.96B derived: sum of 4 quarters · filed 2023-07-24 |
| 2022-03-31 | $1.49B 10-Q · filed 2023-04-20 | $3.04B derived: sum of 2 quarters · filed 2023-04-20 | $4.44B derived: sum of 3 quarters · filed 2023-04-20 | $5.91B derived: sum of 4 quarters · filed 2023-04-20 |
| 2021-12-31 | $1.55B 10-K · filed 2022-02-03 | $2.95B derived: sum of 2 quarters · filed 2022-10-21 | $4.42B derived: sum of 3 quarters · filed 2022-10-21 | $5.71B 10-K · filed 2024-01-31 |
| 2021-09-30 | $1.40B 10-Q · filed 2022-10-21 | $2.87B derived: sum of 2 quarters · filed 2022-10-21 | $4.16B 10-Q · filed 2022-10-21 | $5.49B derived: sum of 4 quarters · filed 2022-10-21 |
| 2021-06-30 | $1.46B 10-Q · filed 2022-07-22 | $2.76B 10-Q · filed 2022-07-22 | $4.09B derived: sum of 3 quarters · filed 2022-07-22 | $5.16B derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-03-31 | $1.29B 10-Q · filed 2022-04-22 | $2.62B derived: sum of 2 quarters · filed 2022-04-22 | $3.70B derived: sum of 3 quarters · filed 2022-04-22 | $4.55B derived: sum of 4 quarters · filed 2022-04-22 |
| 2020-12-31 | $1.33B 10-K · filed 2022-02-03 | $2.41B derived: sum of 2 quarters · filed 2022-02-03 | $3.26B derived: sum of 3 quarters · filed 2022-02-03 | $4.36B 10-K · filed 2023-02-10 |
| 2020-09-30 | $1.08B 10-K · filed 2022-02-03 | $1.93B derived: sum of 2 quarters · filed 2022-02-03 | $3.03B 10-Q · filed 2021-10-20 | $4.31B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | $852.10M 10-K · filed 2022-02-03 | $1.95B 10-Q · filed 2021-07-21 | $3.23B derived: sum of 3 quarters · filed 2022-02-03 | $4.36B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $1.10B 10-K · filed 2022-02-03 | $2.38B derived: sum of 2 quarters · filed 2022-02-03 | $3.51B derived: sum of 3 quarters · filed 2022-02-03 | $4.60B derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | $1.28B 10-K · filed 2021-02-10 | $2.41B derived: sum of 2 quarters · filed 2021-02-10 | $3.50B derived: sum of 3 quarters · filed 2021-02-10 | $4.48B 10-K · filed 2022-02-03 |
| 2019-09-30 | $1.13B 10-K · filed 2021-02-10 | $2.23B derived: sum of 2 quarters · filed 2021-02-10 | $3.20B 10-Q · filed 2020-10-19 | $4.25B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $1.10B 10-K · filed 2021-02-10 | $2.07B 10-Q · filed 2020-07-23 | $3.12B derived: sum of 3 quarters · filed 2021-02-10 | $4.04B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $973.70M 10-K · filed 2021-02-10 | $2.02B derived: sum of 2 quarters · filed 2021-02-10 | $2.94B derived: sum of 3 quarters · filed 2021-02-10 | $3.85B derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $1.05B 10-K · filed 2020-02-07 | $1.97B derived: sum of 2 quarters · filed 2020-02-07 | $2.88B derived: sum of 3 quarters · filed 2020-02-07 | $3.72B 10-K · filed 2021-02-10 |
| 2018-09-30 | $920.90M 10-K · filed 2020-02-07 | $1.83B derived: sum of 2 quarters · filed 2020-02-07 | $2.68B 10-Q · filed 2019-10-18 | $3.57B derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-06-30 | $909.30M 10-K · filed 2020-02-07 | $1.76B 10-Q · filed 2019-07-22 | $2.65B derived: sum of 3 quarters · filed 2020-02-07 | $3.46B derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-03-31 | $847.50M 10-K · filed 2020-02-07 | $1.74B derived: sum of 2 quarters · filed 2020-02-07 | $2.55B derived: sum of 3 quarters · filed 2020-02-07 | $3.31B derived: sum of 4 quarters · filed 2020-02-07 |
| 2017-12-31 | $892.00M 10-K · filed 2019-02-04 | $1.70B derived: sum of 2 quarters · filed 2019-02-04 | $2.46B derived: sum of 3 quarters · filed 2019-02-04 | $3.14B 10-K · filed 2020-02-07 |
| 2017-09-30 | $807.80M 10-K · filed 2019-02-04 | $1.57B derived: sum of 2 quarters · filed 2019-02-04 | $2.25B 10-Q · filed 2018-10-22 | |
| 2017-06-30 | $758.80M 10-K · filed 2019-02-04 | $1.44B 10-Q · filed 2018-07-20 | ||
| 2017-03-31 | $679.60M 10-K · filed 2019-02-04 | |||
| 2016-12-31 | $2.71B 10-K · filed 2019-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |